• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

优化冠心病血运重建策略，以实现患者的最佳获益。

Optimizing revascularization strategies in coronary artery disease for optimal benefit to patients.

机构信息

Cardiovascular Center, OLV Hospital and Cardiovascular Research Center, Aalst, Belgium.

出版信息

Clin Pharmacol Ther. 2011 Oct;90(4):630-3. doi: 10.1038/clpt.2011.162. Epub 2011 Aug 31.

DOI:10.1038/clpt.2011.162
PMID:21881563
Abstract

Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have undergone substantial technological advances, and revascularization is an established therapeutic option in the treatment of coronary artery disease (CAD). Here we focus on optimization of decision making in revascularization strategies, as is being addressed in recent large clinical trials and the guidelines issued by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

摘要

冠状动脉旁路移植术（CABG）和经皮冠状动脉介入治疗（PCI）都取得了重大的技术进步，血运重建是治疗冠状动脉疾病（CAD）的一种既定治疗选择。在这里，我们重点关注血运重建策略决策的优化，这是最近大型临床试验和欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）发布的指南所涉及的问题。

相似文献

1
Optimizing revascularization strategies in coronary artery disease for optimal benefit to patients.优化冠心病血运重建策略，以实现患者的最佳获益。
Clin Pharmacol Ther. 2011 Oct;90(4):630-3. doi: 10.1038/clpt.2011.162. Epub 2011 Aug 31.
2
Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.欧洲心脏病学会和欧洲心胸外科学会指南对稳定型冠状动脉疾病血运重建策略的影响：经皮冠状动脉介入治疗和冠状动脉旁路移植术的活动变化。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):606-10. doi: 10.1016/j.jtcvs.2013.01.026. Epub 2013 Feb 10.
3
[ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].[欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：2014年修订版]
Herz. 2014 Dec;39(8):913-8. doi: 10.1007/s00059-014-4180-4.
4
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014 欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组。由欧洲经皮心血管介入协会（EAPCI）提供特别贡献制定。
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92. doi: 10.1093/ejcts/ezu366. Epub 2014 Aug 29.
5
Discrepancy between the European clinical guidelines and myocardial revascularization in patients with stable coronary artery disease in Russia.俄罗斯稳定型冠状动脉疾病患者的欧洲临床指南与血运重建治疗之间的差异。
Int J Qual Health Care. 2019 May 1;31(4):269-275. doi: 10.1093/intqhc/mzy140.
6
Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.对于被归类为经皮冠状动脉介入治疗推荐等级为II级和III级的患者，在接受传统冠状动脉搭桥术治疗左主干病变后的长期预后及比较。
Eur J Cardiothorac Surg. 2014 Mar;45(3):431-7. doi: 10.1093/ejcts/ezt429. Epub 2013 Aug 26.
7
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组编写，欧洲经皮心血管介入协会（EAPCI）提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
8
Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.冠状动脉疾病治疗选择中风险与获益的权衡。经皮冠状动脉介入治疗和冠状动脉旁路移植术前瞻性随机临床试验的经验教训。
Minerva Cardioangiol. 2003 Oct;51(5):585-97.
9
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.冠状动脉旁路移植术后与经皮冠状动脉介入治疗术后外科手术的发生率及转归：来自京都PCI/CABG注册队列2的冠状动脉血运重建疗效研究报告
Circ Cardiovasc Interv. 2014 Aug;7(4):482-91. doi: 10.1161/CIRCINTERVENTIONS.113.001056. Epub 2014 Jul 29.
10
Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery.2型糖尿病患者晚期冠状动脉疾病的血运重建：在经皮冠状动脉介入治疗（PCI）与外科手术之间做出明智选择
Curr Cardiol Rep. 2017 May;19(5):37. doi: 10.1007/s11886-017-0849-7.

引用本文的文献

1
Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.冠状动脉旁路移植术与经皮冠状动脉介入治疗急性心力衰竭。
Heart. 2020 Jan;106(1):50-57. doi: 10.1136/heartjnl-2018-313242. Epub 2018 Sep 12.
2
Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?高钾心脏停搏液在成人和儿科手术中的应用：一个时代的终结？
Front Physiol. 2013 Aug 28;4:228. doi: 10.3389/fphys.2013.00228. eCollection 2013.